Skip to main content

Table 1 Patients' baseline and disease characteristics

From: Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Characteristics Patients (n = 61)
Median age, years (range) 60 (31-80)
Gender, n (%):  
   Male 39 (64)
   Female 22 (36)
WHO performance status, n (%)  
   0 52 (85)
   1 9 (15)
TN clinical stage, n (%)  
   T3N0 12 (19.7)
   T2N1 1 (1.7)
   T3N1 19 (31.1)
   T2N2 2 (3.3)
   T3N2 22 (36.1)
   T4N2 5 (8.2)
Median clinical tumour size per MRI, cm (range) 6 (1-12)
Median tumour distance from anal verge, cm (range) 6 (0-11)
Type of surgerya, n (%)  
   Low anterior resection 35 (57.4)
   Coloanal reconstruction 10 (16.4)
   Abdominoperineal resection 14 (23.0)
   Pelvic exenteration 2 (3.3)
  1. aAs planned before the start of preoperative chemoradiotherapy.
  2. MRI, magnetic nuclear imaging; N, node; T, tumour; WHO, World Health Organization.